Clicky

NCCN Policy Summit Explores the Promise and Challenges of New Technologies in Cancer Care

National Comprehensive Cancer Network webinar attendees discuss the potential of new technologies to improve cancer care while recognizing potential for improvement.

PLYMOUTH MEETING, PA., September 9, 2021 / PRNewswire / – The National Comprehensive Cancer Network® (NCCN®) convened today NCCN Policy Summit on The Impact of Technology on Cancer Care in 2021. The online program brought together experts and innovators using new technologies to improve the quality, efficiency and accessibility of cancer care at the national and local levels.

NCCN logo (C) NCCN (R) 2018. All rights reserved.

NCCN logo (C) NCCN (R) 2018. All rights reserved.

“We recognize that the use of technology offers tremendous opportunities to fill gaps in our healthcare system to provide better care, reduce doctor burnout and control costs for people with cancer,” said Robert W. Carlson, MD, Managing Director, NCCN. “At the same time, we must worry about inadvertently exacerbating existing problems and creating new areas of bias and inequality can be made with technology, and most importantly, what? should be done.”

“The National Cancer Institute (NCI) ‘s Cancer Imaging Program (CIP) supports innovative research to discover, develop technology and implement new imaging techniques in clinical practice for people with cancer,” said keynote speaker Janet Eary, MD, Deputy Director, chip. “In addition to many activities, CIP maintains a large archive of imagery as a public research resource that promotes new imaging and data analytics that can be used to address equity issues. The archive image data sets with their clinical metadata are collected from different population groups so that researchers can apply innovative imaging research and data analysis approaches to these reference examples. “

Dr. Eary also reported that “imaging research continues to develop innovative approaches that can be used to meet the needs of individuals and diverse populations of cancer patients.”

Panellists examined some of the areas where technology has the greatest potential to improve care and also addressed areas of concern.

“Digital tools and technologies are integrating into our daily lives,” said Edmondo Robinson, MD, MBA, Senior Vice President, Chief Digital Officer, Moffitt Cancer Center. “Health policy is increasingly recognizing these possibilities, from telemedicine to artificial intelligence and beyond; this has been accelerated by the COVID-19 pandemic. In oncology, we can do a lot more to really harness the power and potential of digital tools for prevention “and cure cancer.”

In addition to imaging, the most important topics were of interest:

  • Monitor patient experiences between visits

  • Proactive management of symptoms and side effects before hospitalization is required

  • Better decision support for clinicians

  • Integrate the technology more seamlessly into the clinician’s workflow

  • Improving patient engagement and access to information

  • Data analysis using machine learning

  • Addressing greater inclusion of underrepresented populations in the clinical dataset and raising awareness of social determinants of health

  • Overcoming regulatory hurdles and infrastructure differences

The program also included several presentations presenting some recently developed tools designed to improve the cancer pathway for patients and caregivers.

“We have the LLS health manager™ mobile app because we saw the need for a tool that patients can use to track their daily health. Managing side effects is an important part of cancer care, and by tracking medication, side effects, food, and hydration, patients and their doctors can begin to see patterns and develop strategies to help them do so, “said Amanda LaRussa, Director, Patient Education & Web Content, the Leukemia and Lymphoma Society (LLS). “We also created a free painting app called LLS coloring for children™ is designed to allow children to express their creativity as they learn more about blood cancer and its treatments. It was important to us to provide children with a fun and encouraging platform to help them cope with the emotional challenges that come with being diagnosed with cancer. “Both are free to download from the App Store or Google Play.

Additional quotes from speakers and speakers:

Laura chavaree, LCSW, MSW, Head of patient engagement, Blue Note Therapeutics called:
“The inevitable stress that accompanies a cancer diagnosis often leads to anxiety and depression. Unfortunately, cancer care teams have limited resources and time to provide psychosocial care, and cancer-related stress can go undetected or even go undetected. Blue Note Therapeutics is We Sit Down to meet this unmet need by using clinically validated digital technologies to provide better access to the full range of treatments for cancer-related conditions in top cancer centers. Working closely with patient advisors, we are developing these exciting new tools and a future where technology enables clinicians to expand their reach and empower patients to better manage the emotional stress of cancer at home in their free time. “

James Hamrick, MD, MPH, Vice President, Clinical Oncology, Flatiron health called:
“Machine learning-based tools have the potential to improve patient care and safety through more efficient healthcare. At Flatiron Health, we use machine learning to proactively identify patients who are at risk for an adverse clinical event, and bring these insights directly into clinical workflows. ”To help care teams better target resources to patients, that you need most. As part of this investment, we developed a rigorous analytics solution monitoring model to mitigate the very real risk of reproducing real inequalities in machine learning algorithms. “

Kjel Johnson, PharmD, Vice President, Special Strategy and Customer Solutions, CVS maintenance symbol called:
“A diagnosis of cancer can be overwhelming. What makes it even more difficult is that the treatment pathway is fraught with glitches – from diagnosing patients in a timely manner to making sure they are getting the therapy most appropriate for their specific diagnosis as soon as possible. The use of technology-based solutions can close these gaps and improve the overall quality of care. “

“CVS Health has more than invested $ 100 Millions into its digital infrastructure to help patients get the right treatments faster, mitigate adverse events, and avoid unnecessary recordings to improve the overall quality and cost of care, “added Johnson.

Additional speakers and moderators included:

Kim Agricola, Director, Digital Content, Community in Support of Cancer

Vanessa Cramer, Policy Director, Ovarian Cancer Research Alliance

Jonathan Darer, MD, MPH, chief doctor, Medicalis, Medical Director for Clinical Decision Support, Principal key expert for clinical pathways and decision support, Siemens Healthineers

Tim Foley, MBA, Vice President, Oncology, Preferably

Tufia Haddad, MD, Chair for practical innovation and platform, Mayo Clinic Cancer Center, Medical director of home care, Center for digital health

Jocelyn Ulrich, MPH, Deputy Vice President, Medical Innovation Policy, The Pharmaceutical Research and Manufacturers of America (PhRMA)

The next political summit will be the annual NCCN Patient Advocacy Summit, which will be held on September 13, 2009 Tuesday, December 7th, 2021. This year’s NCCN Patient Advocacy Summit will focus on advances in precision medicine and the implications for quality, accessible, and equal cancer care. To register, visit NCCN.org/summits and join the conversation with the hashtag #NCCNDirective.

Via the National Comprehensive Cancer Network
The national comprehensive cancer network® (NCCN®) is a non-profit alliance of leading cancer centers Dedicated to patient care, research and education. NCCN is committed to improving and facilitating high quality, effective, efficient, and accessible cancer treatment so that patients can lead better lives. The NCCN Guidelines for Clinical Practice in Oncology (NCCN guidelines®) Provide transparent, evidence-based consensus recommendations from experts in cancer care, prevention and support services; They are the recognized standard for clinical direction and policy in cancer treatment and the most thorough and most frequently updated guidelines for clinical practice available in any area of medicine. the NCCN guidelines for patients® Providing expert cancer care information to educate and empower patients and caregivers by helping the NCCN Foundation®. NCCN is also making progress further education, global initiatives, politics, and research cooperation and publication in oncology. visit NCCN.org for more information and follow NCCN on Facebook @NCCNorg, Instagram @NCCNorgand twitter @NCCN.

Media contact:
Rachel Darwin
267-622-6624
darwin@nccn.org

Cision

Cision

View the original content to download multimedia:https://www.prnewswire.com/news-releases/nccn-policy-summit-explores-the-promise-and-challenges-of-new-technologies-in-cancer-care-301372705.html

SOURCE National Comprehensive Cancer Network

-